Target Binding Experiments

Case: In vitro pharmacological efficacy assay of DS-8201a (an ADC drug targeting HER2). 


图片16.png图片8.png

Fig. Binding assay of DS-8201a in different cancer cell lines


GPT Advantages


  • Extensive library of target cells (300+ cancer cell lines and humanized cell lines) and certified BSL-2 level laboratories.

  • Free provision of comparator antibody therapy for common viral infections.

  • Proficient in Flow Cytometry and molecular analysis platforms.

  • Immune system humanized mice available for functional verification of Fc effects (ADCC, ADCP, etc.) on ADC drug antibodies, including NCG-IL15, NCG-IL2, and NCG-SGM3 models.

  • Vast project experience.

  • Compliance with regulatory requirements for new drug application submissions.

  • Strict laboratory data storage standards ensure experiment traceability.


Data request in progress, please wait…